Growth Metrics

Erasca (ERAS) Total Liabilities (2020 - 2026)

Erasca posted quarterly Total Liabilities of $67.7 million for Q1 2026, down 5.63% year-on-year from $71.7 million in Q1 2025, and down 4.62% on a QoQ basis from $71.0 million in Q4 2025.

Erasca (ERAS) has 7 years of Total Liabilities data on file, last reported at $67.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Liabilities fell 5.63% year-over-year to $67.7 million; the trailing twelve-month figure through Mar 2026 stood at $67.7 million (down 5.63% YoY), and the FY2025 full-year result was $71.0 million, down 10.18% from the prior year.
  • Total Liabilities for Q1 2026 stood at $67.7 million, down from $71.0 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $103.1 million in Q4 2022 and bottomed at $49.8 million in Q2 2022.
  • The 5-year median for Total Liabilities is $78.0 million (2023), against an average of $74.9 million.
  • Peak annual rise in Total Liabilities reached 154.09% in 2022, while the deepest fall reached 60.69% in 2022.
  • A 5-year view of Total Liabilities shows it stood at $103.1 million in 2022, then decreased by 23.72% to $78.6 million in 2023, then rose by 0.53% to $79.0 million in 2024, then dropped by 10.18% to $71.0 million in 2025, then retreated by 4.62% to $67.7 million in 2026.
  • The last three Total Liabilities figures came in at $67.7 million (Q1 2026), $71.0 million (Q4 2025), and $72.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 16.35 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.74 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 731.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 177.22 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 19.51 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 7.12 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 10.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 9.45 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.05 Bn
10 Erasca 4.21 Bn 3.97 Bn - 67.71 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 67.71 Mn
Dec 31, 2025 70.98 Mn
Sep 30, 2025 72.52 Mn
Jun 30, 2025 73.13 Mn
Mar 31, 2025 71.74 Mn
Dec 31, 2024 79.03 Mn
Sep 30, 2024 78.85 Mn
Jun 30, 2024 74.66 Mn
Mar 31, 2024 81.61 Mn
Dec 31, 2023 78.61 Mn
Sep 30, 2023 80.43 Mn
Jun 30, 2023 77.96 Mn
Mar 31, 2023 81.09 Mn
Dec 31, 2022 103.06 Mn
Sep 30, 2022 81.11 Mn
Jun 30, 2022 49.76 Mn
Mar 31, 2022 50.81 Mn
Dec 31, 2021 44.89 Mn
Sep 30, 2021 38.96 Mn
Jun 30, 2021 19.58 Mn
Mar 31, 2021 129.26 Mn
Dec 31, 2020 17.40 Mn
Sep 30, 2020 52.82 Mn
Jun 30, 2020 42.55 Mn